{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:41:45Z","timestamp":1790628105453,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/leu.2009.17","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T13:02:01Z","timestamp":1234443721000},"page":"1073-1079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol"],"prefix":"10.1038","volume":"23","author":[{"given":"V H J","family":"Van der Velden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M W J C","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Panzer-Gr\u00fcmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schrauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Marschalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L L","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Den Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J M","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"BFleu200917_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","volume":"96","author":"A Biondi","year":"2000","unstructured":"Biondi A, Cimino G, Pieters R, Pui CH . Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24\u201333.","journal-title":"Blood"},{"key":"BFleu200917_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng765","volume":"30","author":"SA Armstrong","year":"2002","unstructured":"Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41\u201347.","journal-title":"Nat Genet"},{"key":"BFleu200917_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.leu.2404578","volume":"21","author":"MW Jansen","year":"2007","unstructured":"Jansen MW, Corral L, van der Velden VH, Panzer-Grumayer R, Schrappe M, Schrauder A et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007; 21: 633\u2013641.","journal-title":"Leukemia"},{"key":"BFleu200917_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2141.2005.05754.x","volume":"131","author":"A Li","year":"2005","unstructured":"Li A, Goldwasser MA, Zhou J, Armstrong SA, Wang H, Dalton V et al. Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias. Br J Haematol 2005; 131: 185\u2013192.","journal-title":"Br J Haematol"},{"key":"BFleu200917_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2141.2005.05909.x","volume":"132","author":"RW Stam","year":"2006","unstructured":"Stam RW, den Boer ML, Pieters R . Towards targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol 2006; 132: 539\u2013551.","journal-title":"Br J Haematol"},{"key":"BFleu200917_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.leu.2404577","volume":"21","author":"G Mann","year":"2007","unstructured":"Mann G, Cazzaniga G, van der Velden VH, Flohr T, Csinady E, Paganin M et al. Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: the \u2018big sister\u2019 of the infant disease? Leukemia 2007; 21: 642\u2013646.","journal-title":"Leukemia"},{"key":"BFleu200917_CR7","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","volume":"14","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000; 14: 2205\u20132222.","journal-title":"Leukemia"},{"key":"BFleu200917_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","volume":"370","author":"R Pieters","year":"2007","unstructured":"Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240\u2013250.","journal-title":"Lancet"},{"key":"BFleu200917_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM van Dongen","year":"1998","unstructured":"van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731\u20131738.","journal-title":"Lancet"},{"key":"BFleu200917_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0140-6736(01)06355-3","volume":"358","author":"C Eckert","year":"2001","unstructured":"Eckert C, Biondi A, Seeger K, Cazzaniga G, Hartmann R, Beyermann B et al. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet 2001; 358: 1239\u20131241.","journal-title":"Lancet"},{"key":"BFleu200917_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1365-2141.2003.04394.x","volume":"122","author":"N Goulden","year":"2003","unstructured":"Goulden N, Bader P, Van Der Velden V, Moppett J, Schilham M, Masden HO et al. Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia. Br J Haematol 2003; 122: 24\u201329.","journal-title":"Br J Haematol"},{"key":"BFleu200917_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Bruggemann","year":"2006","unstructured":"Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006; 107: 1116\u20131123.","journal-title":"Blood"},{"key":"BFleu200917_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VHJ van der Velden","year":"2003","unstructured":"van der Velden VHJ, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJM . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013\u20131034.","journal-title":"Leukemia"},{"key":"BFleu200917_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/leu.2008.5","volume":"22","author":"T Flohr","year":"2008","unstructured":"Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van der Velden V, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771\u2013782.","journal-title":"Leukemia"},{"key":"BFleu200917_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998; 351: 550\u2013554.","journal-title":"Lancet"},{"key":"BFleu200917_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.leu.2404082","volume":"20","author":"T Burmeister","year":"2006","unstructured":"Burmeister T, Marschalek R, Schneider B, Meyer C, Gokbuget N, Schwartz S et al. Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia 2006; 20: 451\u2013457.","journal-title":"Leukemia"},{"key":"BFleu200917_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/biot.200600037","volume":"1","author":"C Meyer","year":"2006","unstructured":"Meyer C, Kowarz E, Schneider B, Oehm C, Klingebiel T, Dingermann T et al. Genomic DNA of leukemic patients: target for clinical diagnosis of MLL rearrangements. Biotechnol J 2006; 1: 656\u2013663.","journal-title":"Biotechnol J"},{"key":"BFleu200917_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1073\/pnas.0406994102","volume":"102","author":"C Meyer","year":"2005","unstructured":"Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005; 102: 449\u2013454.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200917_CR19","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Bruggemann M, Evans PAS, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunogloulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Leukemia 2003; 17: 2257\u20132317.","journal-title":"Leukemia"},{"key":"BFleu200917_CR20","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1182\/blood-2003-08-2952","volume":"103","author":"T Szczepanski","year":"2004","unstructured":"Szczepanski T, van der Velden VHJ, Hoogeveen PG, De Bie M, Jacobs DCH, Van Wering ER et al. V{delta}2-J{alpha} gene rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood 2004; 103: 3798\u20133804.","journal-title":"Blood"},{"key":"BFleu200917_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/sj.leu.2402206","volume":"15","author":"T Szczepanski","year":"2001","unstructured":"Szczepanski T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJM . Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001; 15: 1415\u20131423.","journal-title":"Leukemia"},{"key":"BFleu200917_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","volume":"14","author":"OJ Verhagen","year":"2000","unstructured":"Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426\u20131435.","journal-title":"Leukemia"},{"key":"BFleu200917_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2401245","volume":"13","author":"MJ Pongers-Willemse","year":"1999","unstructured":"Pongers-Willemse MJ, Seriu T, Stolz F, d\u2019Aniello E, Gameiro P, Pisa P et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110\u2013118.","journal-title":"Leukemia"},{"key":"BFleu200917_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.leu.2403263","volume":"18","author":"M Bruggemann","year":"2004","unstructured":"Bruggemann M, van der Velden VH, Raff T, Droese J, Ritgen M, Pott C et al. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia 2004; 18: 709\u2013719.","journal-title":"Leukemia"},{"key":"BFleu200917_CR25","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","volume":"16","author":"VHJ van der Velden","year":"2002","unstructured":"van der Velden VHJ, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJM . T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: 1372\u20131380.","journal-title":"Leukemia"},{"key":"BFleu200917_CR26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/sj.leu.2402475","volume":"16","author":"VHJ van der Velden","year":"2002","unstructured":"van der Velden VHJ, Willemse MJ, van der Schoot CE, Hahlen K, van Wering ER, van Dongen JJM . Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928\u2013936.","journal-title":"Leukemia"},{"key":"BFleu200917_CR27","first-page":"679","volume":"91","author":"VH van der Velden","year":"2006","unstructured":"van der Velden VH, de Bie M, van Wering ER, van Dongen JJ . Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease. Haematologica 2006; 91: 679\u2013682.","journal-title":"Haematologica"},{"key":"BFleu200917_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/gcc.10167","volume":"36","author":"T Langer","year":"2003","unstructured":"Langer T, Metzler M, Reinhardt D, Viehmann S, Borkhardt A, Reichel M et al. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer 2003; 36: 393\u2013401.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu200917_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1365-2141.2003.04740.x","volume":"124","author":"M Metzler","year":"2004","unstructured":"Metzler M, Brehm U, Langer T, Viehmann S, Borkhardt A, Stanulla M et al. Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11). Br J Haematol 2004; 124: 47\u201354.","journal-title":"Br J Haematol"},{"key":"BFleu200917_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/gcc.20336","volume":"45","author":"BW Robinson","year":"2006","unstructured":"Robinson BW, Slater DJ, Felix CA . BglII-based panhandle and reverse panhandle PCR approaches increase capability for cloning der(II) and der(other) genomic breakpoint junctions of MLL translocations. Genes Chromosomes Cancer 2006; 45: 740\u2013753.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu200917_CR31","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/sj.onc.1204401","volume":"20","author":"M Reichel","year":"2001","unstructured":"Reichel M, Gillert E, Angermuller S, Hensel JP, Heidel F, Lode M et al. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 2001; 20: 2900\u20132907.","journal-title":"Oncogene"},{"key":"BFleu200917_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VH van der Velden","year":"2007","unstructured":"van der Velden VH, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER et al. Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 2007; 21: 604\u2013611.","journal-title":"Leukemia"},{"key":"BFleu200917_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/sj.leu.2404535","volume":"21","author":"VH van der Velden","year":"2007","unstructured":"van der Velden VH, Panzer-Grumayer ER, Cazzaniga G, Flohr T, Sutton R, Schrauder A et al. Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 2007; 21: 706\u2013713.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200917","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:34:58Z","timestamp":1648730098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFleu200917"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.17","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]},"assertion":[{"value":"5 December 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}